Scientists Discover a Surprising New Target for Treating Type 2 Diabetes
Reported bySciTechDaily ↗·Sourced by Goodlede
Researchers at Pennington Biomedical Research Center identified Miro1, a protein found in high amounts in people with Type 2 diabetes, as a key driver of insulin resistance; removing it restored insulin responsiveness in preclinical models, and aerobic exercise reduced Miro1 levels in a randomized trial of participants with obesity and Type 2 diabetes.
Preclinical experiments show Miro1 can influence insulin responses; human trials show exercise reduces it alongside improved insulin sensitivity, but do not yet prove that Miro1 reduction causes exercise's benefits.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at SciTechDaily
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Equality
Delhi women reclaim the outdoors on group nature walks, defying harassment
Guardian Global Development · Verified
Animals
Muskrats, Reshaping Chicago Wetlands for Marsh Birds
Audubon · Verified
Science
Ancient Martian meteorite found in Sahara Desert formed more than 4.1 billion years ago
NASA Jet Propulsion Laboratory (JPL) · Verified